Kinfo
NeuroOne Medical Technologies Corporation logo

NeuroOne Medical Technologies Corporation

NMTCNASDAQHealthcare·US · USD
$1.11
-0.02 (-1.77%)
Prices as of October 7, 2026 · market closed

Price

Key statistics

Valuation
Market cap10.29M USD
Enterprise value8.42M USD
Trailing P/E-2.04
Forward P/E-4.04
PEG ratio-0.07
Price / sales0.83
Price / book2.61
Profitability
Gross margin59.94%
Operating margin-122.87%
Profit margin-59.71%
Return on assets-58.07%
Return on equity-124.66%
Income (TTM)
Revenue12.47M USD
Gross profit2.87M USD
EBITDA-7.66M USD
Net income-7.45M USD
Diluted EPS-$0.99
Rev. growth (YoY)16.30%
Balance sheet
Total cash2.05M USD
Total debt175.34K USD
Debt / equity4.65
Current ratio2.84
Book value / share$0.43
Cash flow (TTM)
Operating cash flow-7.05M USD
Levered free cash flow-4.57M USD
Shares & price
Shares outstanding8.70M
Float6.26M
Held by institutions22.45%
Beta0.76
50-day MA$1.61
200-day MA$3.57
52-week high$6.72
52-week low$0.96
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-13-0.22-0.28−27.27%2026-06-25-0.14-0.16−14.29%2026-05-062.552.72+6.67%2026-02-17-0.24-0.18+25.00%
About NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation is a medical technology company focused on diagnostic and therapeutic solutions for neurological disorders. The company develops and commercializes thin-film electrode technology for continuous electroencephalogram and stereoelectroencephalography recording, along with minimally invasive systems for brain ablation, stimulation, and drug delivery. Its product portfolio includes Evo cortical electrodes, Evo sEEG electrodes, and OneRF ablation systems designed for neurosurgery, neurology, and pain management applications. NeuroOne Medical Technologies Corporation serves clinical settings that treat conditions such as epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremor, and chronic pain. Based in Eden Prairie, Minnesota, the company plays a specialized role in the neurotechnology market by supporting more precise monitoring and treatment options for patients with complex brain and nerve-related disorders.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. David A. Rosa M.D.
Employees
18
Headquarters
Eden Prairie, MN, United States
Website
nmtc1.com

Frequently asked questions about NeuroOne Medical Technologies Corporation